Mr. Michael Lee

Project Director
BeiGene Biopharmaceutical Company


9:00 AM Cold Chain Operation at the Biomanufacturing Facility, from Clinical to Commercial Operations | 一次性生物医药工艺平台下的冷链运营

Single-use disposable bioprocessing platform and system have gained rapid acceptance by biopharmaceutical manufacturers worldwide. The major advantages include reducing overall contamination rates, enhancing production throughput efficiency and hence ensuring the manufacture quality and decreasing manufacturing operation and maintenance costs. However, adopting the single-use platforms into legacy system and implementing new processes are challenging in examining many parameters and cost factors to ensure smooth transformation.

In this workshop, early adopters will explain the key factors a biopharm company should consider to adopt the technology.

Key Learning Outcomes:
Ø  Determining the feasibility of single-use systems by considering the volume, production timeline and complexity
Ø  Evaluating the materials, components and system design to control risk and ensure safety
Ø  Selecting the best suppliers with proven delivery history to ensure the system reliability and consistency

一次性生物工艺平台和系统愈来愈被全世界的生物医药生产商所接受,其主要优势包括能够降低总体污染率和提高生产效率,从而确保生产质量、降低生产运营及维护成本。然而,将一次性平台整合到原有系统中并执行新流程挑战巨大,需要审查众多参数和成本因素以确保顺利转型。

在本次研讨会上,一次性生物工艺平台和系统的先驱用户将介绍生物医药公司在采用该科技前应该考虑的关键因素,并重点分享在此生物医药平台下如何保证高效的冷链运营和管理。

关键学习成果:
Ø  考虑规模、生产时间线和复杂度以确定一次性系统的可行性
Ø  评估材料、部件和体系设计以控制风险并保证安全
Ø  选择拥有良好交付记录的最佳供应商以确保系统可靠性和一致性


Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda